EFSA health claim opinions

Barry Callebaut wins article 13.5 chocolate-blood circulation claim; probiotic, rhodiola rejected

By Shane Starling

- Last updated on GMT

Chocolate just got tastier from a health point of view after EFSA backs it for better blood flow
Chocolate just got tastier from a health point of view after EFSA backs it for better blood flow

Related tags: Cholesterol, Nutrition

Swiss chocolate processor Barry Callebaut has won an article 13.5 health claim from the European Food Safety Authority (EFSA) for a dossier linking cocoa flavanols and blood circulation.

But nine other article 13.5, proprietary and emerging science claims were rejected including eight from Swiss firm Nutrilinks and one from Lesaffre International/Lesaffre Human Care:

  • Krill oil and HDL and LDL cholesterol and triglyceride levels
  • Rhodiola and mental fatigue
  • Hyaluronic acid and skin against dehydration
  • Thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, D-biotin ​and pumpkin seed oil (Cucurbita pepo​ L.) and maintenance of normal hair
  • Keratin, copper, zinc, niacin, pantothenic acid, pyridoxine and D-biotin, and maintenance of normal hair
  • Vitamin E and maintenance of skin permeability (all submitted by Nutrilinks)
  • Probiotic strain Saccharomyces cerevisiae​ var. boulardii​  and gastro-intestinal discomfort (Lesaffre International/Lesaffre Human Care)

Callebaut’s approved claim reads: “Cocoa flavanols help  maintain endothelium-dependent vasodilation, which contributes to normal blood flow.”

EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) said this applied when 200mg of cocoa flavanols were consumed daily in the form of 2.5g of high-flavanol cocoa powder or 10g of high-flavanol dark chocolate.

Juergen Steinemann, CEO of Barry Callebaut, said in a statement: "As the first company receiving such a health claim, we see new market potential both for us and for our customers.”

Look to NutraIngredients and our sister site ConfectioneryNews​ for more on this opinion​ later in the week.

The opinion, along with the nine negative opinions will now pass to the European Commission and member states for assessment and validation.

The NDA also rejected an article 14, disease risk factor reduction submission from Health Concern in the Netherlands linking a plant sterol blend and cholesterol reduction.

Related news

Show more

Related products

show more

The Ingredients Show 2019 NEC Birmingham

The Ingredients Show 2019 NEC Birmingham

William Reed | 01-Jan-2019 | Product Brochure

We’ve been bringing food and drink markets together for over 150 years. And the drive to
inform and serve our sectors that fuelled the launch of...

Bioavailability Study of Maqui Berry Extract

Bioavailability Study of Maqui Berry Extract

Anklam Extrakt GmbH | 12-Dec-2018 | Clinical Study

Several health-promoting effects have been reported for the Patagonian maqui berry, which is rich in anthocyanins. Within the course of a study, the bioavailability...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars